News

 
08/12/2021

Pharus Sicav Best Regulated Companies distributes the fourth dividend

Pharus team is pleased to inform that, on December 8, 2021, the fourth semi-annual dividend of...
 
19/10/2021

Biotech: a stop that will not last

This year the healthcare sector, and in particular the small and mid-cap biotechnology companies,...
 
23/09/2021

What impact will inflation have on corporate earnings?

US inflation data for August confirmed the presence of two opposing forces, which contributed...
 
16/09/2021

China: opportunities within the revolution

The regulatory tension that China is facing is also affecting market prices and in particular, as...
 
13/08/2021

The BoLe Chronicle | August 2021

ESG with Chinese characteristics 'Now, what if yours truly tell you that the first time he...
 
16/06/2021

Post-COVID, new opportunities for Biotech

There are three main catalysts for the sector: the end of lockdown, the upturn in M&A activities...
 
10/06/2021

Pharus Sicav Best Regulated Companies distributes the third dividend

Pharus team is pleased to inform that, on June 17, 2021, the semi-annual dividend...
 
07/06/2021

The BoLe Chronicle | May 2021

The rise and rise of Asia, yet where are the cheerleaders Have lost count how many years in a...
 
18/05/2021

Inflation: temporary or not?

The market has been hit in recent months by the rise in inflation and although it...